Why Lung Cancer Screening at NYU Langone Medical Center?
On June 29, 2011, the results of the NCI-sponsored National Lung Screening Trial (NLST) were published in the New England Journal of Medicine. The study demonstrated that screening of heavy smokers with CT can decrease lung cancer mortality by 20% compared with chest x-ray. The results were so convincing that the study was terminated ahead of schedule, in order to publish the results as soon as possible. The study definitively demonstrated that lung cancer screening with low dose CT scan can save lives. However, the report stresses that the efficacy of screening depends heavily on the equipment and expertise of those performing the tests.
Expertise & state-of-the-art technology
NYU Langone Medical Center, a pioneer in lung cancer screening, has both state-of-art CT equipment and the highest caliber medical experts to ensure that screening is done appropriately, safely and with proper follow-up and oversight. With some of the foremost thoracic radiologists in the region. NYU Langone Medical Center radiologists pioneered the use of CT scans for lung cancer screening in the 1990s, and, with collaborators at Cornell University Medical Center, published the original US study on the subject in 2000.
Our expertise is built on our Thoracic Radiology Department’s depth and breadth of experience in lung cancer screening. Members of the team sit on national scientific committees to establish guidelines on interpretation and management of CT abnormalities discovered at screening. Most importantly, the NYU Langone Medical Center Department of Radiology is a leader in patient safety and attention to minimizing radiation exposure. What this means is that we utilize a “low dose technique” on cutting edge equipment to ensure the safest procedures and the most reliable results.
Leaders in research
The NYU Langone Medical Center Division of Pulmonary and Critical Care Medicine has been in the forefront of research in the early detection of lung cancer. Since 2000 NYU has been a part of the Early Detection Research Network (EDRN) of the National Cancer Institute. Over 1500 individuals have participated in the NYU Lung Cancer Biomarker Center of the EDRN, undergoing CT scans for lung cancer screening under the supervision of the Division of Pulmonary Medicine. We have diagnosed more than 30 early-stage lung cancers
Multidisciplinary teams within an NCI-designated Cancer Center
If CT screening leads to a diagnosis of a lung cancer, experts at NYU Cancer Institute are prepared to guide you through the process of treatment and recovery. NYU Langone Medical Center has world-renowned specialists including thoracic surgeons and medical oncologists and radiation oncologists. Receiving your care in one location, under a single coordinated team, ensures optimal management with minimal chance of duplications and omissions in your treatment.